Amy Ly
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Lesions and Carcinomas 9
- Lymphoma Diagnosis and Treatment 7
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 4
- Co-authors
- Elena F. Brachtel (5 shared papers)Deborah A. R. Dillon (2 shared papers)Susan C. Lester (2 shared papers)Bariş Boyraz (2 shared papers)Emily Reisenbichler (1 shared paper)Hakho Lee (2 shared papers)Ronald Arpin (2 shared papers)Jane E. Brock (1 shared paper)
- Journals
- The Journal of Pathology (4 papers)Modern Pathology (3 papers)Cancer Cytopathology (3 papers)American Journal of Clinical Pathology (2 papers)Human Pathology (2 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Amy Ly
59 papers receiving 2.2k citations
Amy Ly's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 619
- Oncology 600
- Pulmonary and Respiratory Medicine 379
- Pathology and Forensic Medicine 125
- Obstetrics and Gynecology 56
Countries citing papers authored by Amy Ly
This map shows the geographic impact of Amy Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ly more than expected).
Fields of papers citing papers by Amy Ly
This network shows the impact of papers produced by Amy Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ly. The network helps show where Amy Ly may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Ly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 473 | |
| 2 | Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue Hit paper breakdown → | 2022 | 279 |
| 3 | 2019 | 218 | |
| 4 | 2015 | 147 | |
| 5 | 2020 | 144 | |
| 6 | 2020 | 110 | |
| 7 | 2014 | 97 | |
| 8 | 2023 | 66 | |
| 9 | 2013 | 58 | |
| 10 | 2023 | 57 | |
| 11 | 2013 | 53 | |
| 12 | 2020 | 52 | |
| 13 | 2017 | 41 | |
| 14 | 2016 | 39 | |
| 15 | 2023 | 35 | |
| 16 | 2023 | 28 | |
| 17 | 2024 | 27 | |
| 18 | 2016 | 26 | |
| 19 | 2024 | 23 | |
| 20 | 2021 | 22 |
About Amy Ly
Amy Ly is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Artificial Intelligence, having authored 61 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (9 papers), AI in cancer detection (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Breast Cancer Treatment Studies (6 papers), Clinical Laboratory Practices and Quality Control (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (619 citations), Oncology (600 citations), Pulmonary and Respiratory Medicine (379 citations), Pathology and Forensic Medicine (125 citations) and Obstetrics and Gynecology (56 citations). Amy Ly has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Elena F. Brachtel, Deborah A. R. Dillon, Susan C. Lester, Bariş Boyraz, Emily Reisenbichler, Hakho Lee, Ronald Arpin, Jane E. Brock, Chang Yeol Lee and Hyunho Kim. Their work appears in journals such as The Journal of Pathology, Modern Pathology, Cancer Cytopathology, American Journal of Clinical Pathology and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.